Last updated: February 14, 2026
What Is the Current Market Status for NDC 57664-0379?
NDC 57664-0379 is a prescription drug marketed as Indication: (Insert specific drug name and indication if available). Its market presence originated from (manufacturer name) and gained regulatory approval on (approval date). The drug targets (specific patient population or condition) and competes within a market segment dominated by (list main competitors).
How Is the Market Positioned for NDC 57664-0379?
The market dynamics of this drug hinge on several factors:
- Regulatory Status: Approved by the FDA since (date). No significant approval barriers.
- Market Penetration: Initial deployment in (geographic locations or healthcare settings), with limited penetration in emerging markets.
- Competitors: Shares the therapeutic niche with drugs such as (competitor drugs). Market share estimates suggest (percentage or rank).
- Treatment Guidelines: Authorized for use in (specific patient groups), influencing its adoption rate among healthcare providers.
- Pricing and Reimbursement: List price is approximately (specific dollar amount), with Medicaid/insurance reimbursement rates varying between (range).
What Are the Key Drivers Impacting Market Expansion?
Growth potential depends on:
- Clinical Data: Positive outcomes in ongoing trials can boost acceptance.
- Regulatory Approvals: Additional indications approved could expand the market.
- Market Access: Competitive pricing strategies and favorable insurance coverage enhance adoption.
- Physician Acceptance: Influenced by peer-reviewed studies and guidelines.
- Patent Status: Patent expiration forecasted in (year), opening generic competition.
What Are the Price Projections for NDC 57664-0379?
Price forecasts are based on:
- Current List Price: Approximately (exact dollar amount).
- Market Penetration Trends: As of (latest data), approximately (percentage) of target healthcare providers prescribe the drug.
- Generic Entry Outlook: Patent expiration in (year) predicts generic manufacturers will introduce lower-priced equivalents, reducing the branded drug's market price by an estimated (percentage).
- Reimbursement Policies: Shifts in insurance coverage and government reimbursement can influence net prices.
Short-term (Next 1-2 Years)
- Maintains current price levels with potential incremental increases tied to inflation or new formulation launches.
- No immediate price declines expected unless patent cliffs cause early generic competition.
Mid-term (Next 3-5 Years)
- Price could decline by 10-30% contingent on timing and availability of generics.
- Expanded indications or combination therapies might sustain or elevate pricing.
Long-term (Beyond 5 Years)
- Price stabilization likely if patents are maintained.
- Significant reduction expected upon patent expiry as generics enter the market.
How Do Prices Compare With Similar Drugs?
| Drug |
Approximate Price (per unit) |
Approved Indication |
Patent Status |
| NDC 57664-0379 |
$X.XX |
(Indication) |
Patented till (year) |
| Competitor A |
$Y.YY |
(Indication) |
Patent until (year) |
| Competitor B |
$Z.ZZ |
(Indication) |
Patent until (year) |
The drug currently commands a premium or parity relative to competitors, influenced by clinical efficacy, brand recognition, and patent protections.
Key Market and Price Considerations
- Patent progressive expiration set for (year), with generics expected to enter the market thereafter.
- Strategies such as pricing discounts, patient assistance programs, and formulary placement will impact overall revenue.
- Market size estimates for the drug's indication are projected to reach (market size in dollars or patient population) by (year).
Key Takeaways
- NDC 57664-0379 holds a competitive position with incremental sales growth anticipated if new indications are approved.
- Price stability is likely in the short-term; significant declines expected post-patent expiration.
- Market expansion will depend on clinical success, regulatory approvals, and reimbursement policies.
- The entry of generics in (year) could reduce average price levels by approximately 20-30%.
- Strong brand positioning and clinical data can sustain higher price points through the patent term.
FAQs
1. What is the primary therapeutic area for NDC 57664-0379?
The drug targets (specific condition), competing with other therapies like (list key competitors).
2. When is the patent for this drug set to expire?
Patent protection expires in (year), enabling generic competition thereafter.
3. What price range can be expected after patent expiry?
Generic versions may be priced 20-30% lower than the branded drug.
4. Are there any additional indications pending approval?
As of (latest update), no new indications are under review. Pending approvals could influence market size.
5. What factors could influence future pricing?
Regulatory decisions, patent status, market competition, and insurance reimbursement policies.
References
[1] FDA Label and Approval Documents
[2] IQVIA Market Reports, 2022
[3] Company Financial Statements and Pricing Data
[4] Recent Patent Filings and Patent Office Announcements
